J. L. Bainbridge & Co., Inc. Gilead Sciences, Inc. Transaction History

J. L. Bainbridge & Co., Inc.

$1.02 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $43,059 - $48,497	-746 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $40,486 - $50,733	-699 Reduced 48.37%	746 $44,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $15.3 Million - $17.3 Million	-235,146 Reduced 99.39%	1,445 $105,000
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $291,676 - $314,686	-4,309 Reduced 1.79%	236,591 $16.5 Million
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $876,647 - $957,862	-13,812 Reduced 5.42%	240,900 $16.6 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $381,120 - $434,857	6,352 Added 2.56%	254,712 $16.5 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $902,094 - $1.03 Million	-15,924 Reduced 6.03%	248,360 $14.5 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $292,987 - $368,381	-4,718 Reduced 1.75%	264,284 $16.7 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $285,381 - $331,380	3,945 Added 1.49%	269,002 $20.7 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $1.13 Million - $1.45 Million	18,092 Added 7.33%	265,057 $19.8 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $2.42 Million - $2.66 Million	-39,289 Reduced 13.73%	246,965 $16 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $239,475 - $264,339	-3,831 Reduced 1.32%	286,254 $18.1 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $402,031 - $450,831	-6,498 Reduced 2.19%	290,085 $19.6 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $585,530 - $655,948	9,364 Added 3.26%	296,583 $20.1 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $340,295 - $444,059	-5,621 Reduced 1.92%	287,219 $18 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $123,243 - $136,452	-1,729 Reduced 0.59%	292,840 $22.6 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $19.1 Million - $22.3 Million	294,569 New	294,569 $20.9 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.

Account